您的购物车当前为空
别名 MX 1094, LT-NS 001
Naproxen is a COX-1 and COX-2 inhibitor (IC50s: 8.72 and 5.15 μM, respectively in cell assay). Naproxen etemesil is a lipophilic and non-acidic prodrug of naproxen. It is hydrolyzed to pharmacologically active Naproxen once absorbed.


为众多的药物研发团队赋能,
让新药发现更简单!
Naproxen is a COX-1 and COX-2 inhibitor (IC50s: 8.72 and 5.15 μM, respectively in cell assay). Naproxen etemesil is a lipophilic and non-acidic prodrug of naproxen. It is hydrolyzed to pharmacologically active Naproxen once absorbed.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,170 | 5日内发货 | |
| 5 mg | ¥ 1,980 | 5日内发货 | |
| 25 mg | ¥ 8,620 | 6-8周 | |
| 50 mg | ¥ 11,200 | 6-8周 | |
| 100 mg | ¥ 16,200 | 6-8周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,280 | 5日内发货 |
| 产品描述 | Naproxen is a COX-1 and COX-2 inhibitor (IC50s: 8.72 and 5.15 μM, respectively in cell assay). Naproxen etemesil is a lipophilic and non-acidic prodrug of naproxen. It is hydrolyzed to pharmacologically active Naproxen once absorbed. |
| 靶点活性 | COX-1:8.72 μM, COX-2:5.15 μM |
| 体外活性 | Naproxen is a well known nonsteroidal anti-inflammatory drug. Naproxen is an approximately equipotent inhibitor of COX-1 and COX-2 in intact cells (IC50s: 2.2 μg/mL and 1.3 μg/mL, respectively)[1]. |
| 体内活性 | Naproxen is shown to inhibit the time-courses of pain, fever, and PGE2 with similar potencies (IC50=27, 40, 13 μM). Naproxen exerts an anti-inflammatory and antifibrotic effect in the mouse model of bleomycin-induced lung fibrosis. Naproxen also downregulates TGF-β levels and Smad3/4 complex formation [2][3]. |
| 别名 | MX 1094, LT-NS 001 |
| 分子量 | 336.4 |
| 分子式 | C17H20O5S |
| CAS No. | 385800-16-8 |
| Smiles | COc1ccc2cc(ccc2c1)[C@H](C)C(=O)OCCS(C)(=O)=O |
| 密度 | 1.238 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多